In the News

In the News

Share this

Search Results

ArticlesThe Chase for a Permanent Flu Vaccine 04/23/2018
UCLA researchers find promising leads on a replacement for the current annual influenza shots, which vary in their success depending on the strain of virus.

In 2015, Denise Delatorre was diagnosed with aggressive lymphoma. Chemotherapy failed to work. She was given six months to live.

“That day I went home and told my son I was going to die. I actually pulled him out of work and told him that I wasn’t going to make it,” Delatorre recalled as tears welled up in her eyes.

But then the Laguna Beach mother read about a study at UCLA involving a unique immunotherapy called CAR-T cell therapy. She became the first patient to be involved in the clinical trial.

ArticlesImmunotherapy is latest treatment of choice for certain cancers 10/19/2017
A Los Angeles Times article about successfully using immunotherapy drugs to extend the lives of patients featured Dr. Antoni Ribas, professor in the department of hematology and oncology at the David Geffen School of Medicine at UCLA and director of UCLA’s Jonsson Comprehensive Cancer Center Immunology Program.

ArticlesControlling HIV in China 10/19/2017
Ecns.cn profiled Dr. Roger Detels, professor of epidemiology and infectious diseases at the UCLA Fielding School of Public Health and director of the Multicenter AIDS Cohort Study, and his work training health professionals from Asian countries to control the spread of AIDS.

WFMZ-TV, Philadelphia, and Vision Hispana USA reported on the UCLA International Medical Graduate (IMG) program, which helps legal U.S. residents who are medical-school graduates from Latin America earn their California medical licenses. Dr. Michelle Bholat, executive director of the program and executive vice chair of family medicine at UCLA, commented.

International PartnershipsDirector of UCLA Health International Blazing Trail for Chinese Hospital Partnership 06/19/2017
Earlier this month, Director of UCLA Health International Michael Burke touched down in Los Angeles after weeks of traveling between the U.S. and the Guangdong Provence in southeast China. This wasn’t Burke’s first time visiting the area and isn’t expected to be his last. Through UCLA Health’s recent partnership with top Chinese developer R&F Properties and international management firm MedPoint Health Partners, two state-of-the-art hospitals are expected to be completed by January 2020 in Guangdong. UCLA Health is providing consulting services to make this possible.

General$50 Million Donation Given to UCLA Mattel Children’s Hospital 06/15/2017
With a partnership that spans nearly twenty years and includes multiple six figure donations, one might assume Mattel Inc. achieved all they thought possible with UCLA Health. However, when UCLA and Mattel announced this past March that Mattel would be committing $50 million to UCLA Mattel Children’s Hospital, it was clear that they had intended on doing much more. The new gift will help to maintain UCLA Health’s reputation as one of the premiere children’s hospitals in the country, as well as expand UCLA’s activity internationally.

Education and TrainingReport from China: Our Faculty Members Teach and Learn in Hangzhou 04/27/2017
In April 2017 five UCLA Department of Anesthesiology faculty members traveled to Hangzhou to participate in one day joint conference w/ Department of Anesthesiology at the Second Affiliated Hospital of Zhejiang University (SAHZU) on “The Future Of Perioperative Medicine.”